SHAWN MOLLICA: Open Payments
NPI 1811988157 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,730 in 193 payments from 29 companies in 2025. Trend: 2023 $3,752 · 2024 $3,920 · 2025 $3,730
Food & beverage: $3,730
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $563 |
| REVANCE THERAPEUTICS, INC. | 10 | $493 |
| Axsome Therapeutics, Inc. | 23 | $392 |
| AstraZeneca Pharmaceuticals LP | 2 | $213 |
| PFIZER INC. | 21 | $212 |
| Amgen Inc. | 19 | $203 |
| Novartis Pharmaceuticals Corporation | 14 | $200 |
| Janssen Pharmaceuticals, Inc | 10 | $197 |
| Lundbeck LLC | 10 | $183 |
| Novo Nordisk Inc | 10 | $162 |
Products named: DAXXIFY, Auvelity, VRAYLAR, FARXIGA, SPRAVATO, LEQVIO, VYEPTI, Wegovy.
Industry payments across TX — which companies pay providers there.
